Boomers Should Not ...
Health Care: Drugs
NewLink Genetics Corp (NLNK: NASDAQ)
$15.54 -0.25 | -1.58%
05/22/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
|---|
| REVENUE (Trailing 12 Quarters) |
| EARNINGS PER SHARE (Trailing 12 Quarters) |
| DIVIDENDS (Trailing 12 Quarters) |
Portfolios with NLNK
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks With Big Insider Buy...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
Latest NLNK Headlines from TheStreet
- 3 Biotech Stocks Spiking With Big Volume 05.13.13 | 02:05 pm
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 5 Stocks With Big Insider Buying 02.06.13 | 12:02 pm
- Top Insider Trades: FB NLNK GD NOW 02.06.13 | 09:02 am
- Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data 09.25.12 | 08:09 am
- NewLink Announces An Investigator Initiated Phase 2 Study Of Sipuleucel-T Plus Indoximod In The Treatment Of Certain Men With Advanced Prostate Cancer 09.21.12 | 08:09 am
- NewLink CEO To Participate In Panel Entitled "Innovation In Immunotherapy And Vaccines" 09.20.12 | 08:09 am
- NewLink Genetics Corporation Reports Second Quarter 2012 Financial Results 08.14.12 | 08:08 am
- Pharma IPOs Are Good Medicine 07.23.12 | 07:07 am
- 7 Stocks Ripping Higher on Huge Volume 06.11.12 | 01:06 pm
Press Releases for NLNK
- NewLink Genetics To Present At The Needham And Company 12th Annual Healthcare Conference - PR Newswire 04.25.13 | 07:04 am
- NewLink Genetics Presents Preclinical Data On New IDO Pathway Inhibitor, NLG919, At AACR 2013 Annual Meeting - PR Newswire 04.08.13 | 07:04 am
- NewLink Genetics Presents Preclinical Data On NLG919, A New Drug Candidate From A Novel Class Of IDO Pathway Inhibitors For The Treatment Of Cancer - PR Newswire 04.04.13 | 07:04 am
- NewLink Genetics Initiates Phase 2 Trial Of IDO Pathway Inhibitor, Indoximod, For The Treatment Of Metastatic Breast Cancer - PR Newswire 04.02.13 | 07:04 am
- NewLink Genetics Announces Timing Of Fourth Quarter And Year-End 2012 Financial Results Conference Call - PR Newswire 02.25.13 | 11:02 am
- NewLink Genetics Corporation Announces Exercise Of Underwriters' Option And Closing Of Public Offering Of Common Stock - PR Newswire 02.04.13 | 09:02 am
- NewLink Genetics Corporation Announces Pricing Of Public Offering Of Common Stock - PR Newswire 01.30.13 | 09:01 am
- NewLink Genetics Corporation Announces Proposed Public Offering Of Common Stock - PR Newswire 01.29.13 | 04:01 pm
- NewLink Genetics Appoints Mr. Brian Wiley As Vice President Of Business Development - PR Newswire 01.03.13 | 07:01 am
- Clinical Data From NewLink Genetics' HyperAcute Prostate Cancer Immunotherapy Published In Journal Of Immunotherapy - PR Newswire 12.13.12 | 07:12 am
Partner Headlines for NLNK
- A Gold Mine In Biotechnology: The Companies Poised To Benefit - Seeking Alpha 09.04.12 | 09:09 am
- NewLink Genetics DROPS 11% and 4 Stock Analyses Making Waves - Wall St. Cheat Sheet 07.18.12 | 12:07 pm
- These Are Four of the Hottest Biotechs in the Market Right Now - Benzinga 07.05.12 | 01:07 pm
- Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel ... - GuruFocus 06.30.12 | 11:06 am
- Zumiez Lifted Among These Equity Analyst Insights Today - Wall St. Cheat Sheet 06.19.12 | 08:06 am
- Active Stock Alerts: Edwards Lifesciences, Pandora Media, NewLink Genetics, VMware June 6th - Wall St. Cheat Sheet 06.06.12 | 11:06 am
- New Share Price Targets to Evaluate Now - Wall St. Cheat Sheet 06.06.12 | 04:06 am
- Analysts Unveil These New Share Price Targets Tuesday - Wall St. Cheat Sheet 05.29.12 | 03:05 am
- Stock Insights: Costco Wholesale, Human Genome, NewLink Genetics, VeriFone,General Mills May 25th - Wall St. Cheat Sheet 05.25.12 | 10:05 am
- Must Know Share Price Targets That Changed Today - Wall St. Cheat Sheet 05.25.12 | 04:05 am
